METabolic EXplorer recalls that on 12 July 2024, the Paris Commercial Court appointed Avril as purchaser of the activities of METEX NØØVISTAGO and part of the commercial and R&D activities of METabolic Explorer.
In this context, the Court has, by judgment dated today, ordered the conversion into judicial liquidation of the receivership proceedings opened in favour of METEX NØØVISTAGO and METabolic EXplorer.
Investors' attention is drawn to the fact that, as a result of the Court's approval of the sale plan in favour of Avril and the pronouncement of the compulsory liquidations of METEX NØØVISTAGO and METabolic EXplorer, there will be no resumption of trading in METabolic EXplorer shares and Euronext will shortly delist the shares, which will have a zero value. Trading will remain suspended until the delisting operations are completed.
As previously indicated, given the amount of the Group's liabilities, the proceeds from the disposal of the activities of the three Group companies will not enable a payment to be made to METabolic EXplorer's shareholders.
About METabolic EXplorer - www.metabolic-explorer.fr
Contribute to the necessary ecological transition by innovating to produce and market low-carbon functional ingredients used in the manufacture of mass-market products.
Using renewable raw materials, the Group develops and industrialises innovative and competitive industrial fermentation processes as alternatives to petrochemical processes, in response to consumers' new social expectations and the challenges of the energy transition.
Its two industrial units, METEX NØØVISTAGO and METEX NØØVISTA, are enabling the Group to realise its ambition of becoming a world market leader in functional ingredients produced by fermentation for the formulation of cosmetic products, animal feed or the synthesis of biopolymers.
METabolic EXplorer, based at the Clermont Limagne Biopôle near Clermont-Ferrand, is listed on Euronext Paris (Compartment B, METEX) and is included in the CAC Small index.
© 2024 GlobeNewswire (Europe)
